Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease

  • Technology appraisal guidance
  • TA217
  • Published: 
  • Last updated: 

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence